Payment overview · 2025
General Payments
$22.92
1 reported records · 1 companies
Healthcare provider profile · identity verified
Robin Bhasin
Allopathic & Osteopathic Physicians|Internal Medicine|Geriatric Medicine · WINTER PARK, FL · NPI 1841502333
Verified facts
What the public records show
CMS Open Payments records show Robin Bhasin received $22.92 in general payments during 2025 across 1 reported records.
Neurocrine BioSciences, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Neurocrine BioSciences, Inc. | Unresolved — no canonical attribution shown | $22.92 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $22.92 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| INGREZZA Normalized: ingrezza |
Drug | Neurocrine BioSciences, Inc. | $22.92 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 847 | 175 |
| Amlodipine Besylate | Amlodipine Besylate | 674 | 145 |
| Eliquis | Apixaban | 582 | 81 |
| Gabapentin | Gabapentin | 565 | 125 |
| Tamsulosin Hcl | Tamsulosin Hcl | 438 | 88 |
| Levothyroxine Sodium | Levothyroxine Sodium | 385 | 78 |
| Clopidogrel | Clopidogrel Bisulfate | 360 | 69 |
| Levetiracetam | Levetiracetam | 298 | 44 |
| Lisinopril | Lisinopril | 271 | 62 |
| Trazodone Hcl | Trazodone Hcl | 270 | 74 |
| Metformin Hcl | Metformin Hcl | 264 | 59 |
| Metoprolol Tartrate | Metoprolol Tartrate | 262 | 62 |
| Pantoprazole Sodium | Pantoprazole Sodium | 259 | 61 |
| Losartan Potassium | Losartan Potassium | 251 | 66 |
| Mirtazapine | Mirtazapine | 251 | 66 |
| Divalproex Sodium | Divalproex Sodium | 250 | 54 |
| Carvedilol | Carvedilol | 245 | 55 |
| Sertraline Hcl | Sertraline Hcl | 231 | 47 |
| Memantine Hcl | Memantine Hcl | 208 | 32 |
| Hydralazine Hcl | Hydralazine Hcl | 201 | 46 |
| Potassium Chloride | Potassium Chloride | 184 | 52 |
| Furosemide | Furosemide | 181 | 57 |
| Quetiapine Fumarate | Quetiapine Fumarate | 163 | 45 |
| Finasteride | Finasteride | 159 | 32 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 158 | 31 |
| Metoprolol Succinate | Metoprolol Succinate | 158 | 42 |
| Buspirone Hcl | Buspirone Hcl | 154 | 36 |
| Escitalopram Oxalate | Escitalopram Oxalate | 154 | 29 |
| Xarelto | Rivaroxaban | 148 | 19 |
| Donepezil Hcl | Donepezil Hcl | 145 | 36 |
| Baclofen | Baclofen | 143 | 31 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 115 | 22 |
| Jardiance | Empagliflozin | 112 | 20 |
| Risperidone | Risperidone | 105 | 17 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 99 | 23 |
| Doxycycline Hyclate | Doxycycline Hyclate | 97 | 57 |
| Duloxetine Hcl | Duloxetine Hcl | 83 | 25 |
| Latanoprost | Latanoprost | 79 | 24 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 75 | 49 |
| Amiodarone Hcl | Amiodarone Hcl | 73 | 14 |
| Gemtesa | Vibegron | 73 | suppressed |
| Januvia | Sitagliptin Phosphate | 69 | suppressed |
| Allopurinol | Allopurinol | 68 | 18 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 67 | 20 |
| Farxiga | Dapagliflozin Propanediol | 66 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 65 | 24 |
| Lactulose | Lactulose | 63 | 16 |
| Benztropine Mesylate | Benztropine Mesylate | 62 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 62 | 36 |
| Spironolactone | Spironolactone | 62 | 16 |
| Novolog Flexpen | Insulin Aspart | 61 | 18 |
| Lamotrigine | Lamotrigine | 60 | suppressed |
| Cephalexin | Cephalexin | 59 | 38 |
| Hydrochlorothiazide | Hydrochlorothiazide | 59 | 15 |
| Fenofibrate | Fenofibrate Nanocrystallized | 57 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 57 | 12 |
| Meloxicam | Meloxicam | 55 | 13 |
| Ondansetron Hcl | Ondansetron Hcl | 55 | 39 |
| Simvastatin | Simvastatin | 54 | 15 |
| Sucralfate | Sucralfate | 54 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 52 | suppressed |
| Entresto | Sacubitril/Valsartan | 51 | suppressed |
| Nifedipine Er | Nifedipine | 51 | 11 |
| Paroxetine Hcl | Paroxetine Hcl | 51 | suppressed |
| Olanzapine | Olanzapine | 50 | 13 |
| Clonidine Hcl | Clonidine Hcl | 49 | 32 |
| Prednisone | Prednisone | 48 | 27 |
| Divalproex Sodium Er | Divalproex Sodium | 47 | suppressed |
| Bumetanide | Bumetanide | 46 | 12 |
| Fiasp | Insulin Aspart (Niacinamide) | 45 | 12 |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 45 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 44 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 42 | 20 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 42 | suppressed |
| Lyumjev Kwikpen U-100 | Insulin Lispro-Aabc | 42 | suppressed |
| Omeprazole | Omeprazole | 41 | 16 |
| Oxybutynin Chloride | Oxybutynin Chloride | 41 | 13 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 41 | 22 |
| Azithromycin | Azithromycin | 40 | 27 |
| Ropinirole Hcl | Ropinirole Hcl | 40 | suppressed |
| Famotidine | Famotidine | 37 | 16 |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 36 | 14 |
| Aripiprazole | Aripiprazole | 35 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 35 | suppressed |
| Ezetimibe | Ezetimibe | 34 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 34 | suppressed |
| Cefdinir | Cefdinir | 33 | 25 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 33 | 17 |
| Montelukast Sodium | Montelukast Sodium | 33 | 11 |
| Timolol Maleate | Timolol Maleate | 33 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 32 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 32 | suppressed |
| Insulin Lispro | Insulin Lispro | 31 | 18 |
| Myrbetriq | Mirabegron | 31 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 30 | 13 |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 30 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 29 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 29 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 29 | suppressed |
| Valsartan | Valsartan | 29 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 28 | 23 |
| Ceftriaxone | Ceftriaxone Sodium | 28 | 16 |
| Nystatin | Nystatin | 28 | 21 |
| Digoxin | Digoxin | 27 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 26 | suppressed |
| Humalog | Insulin Lispro | 26 | suppressed |
| Topiramate | Topiramate | 26 | suppressed |
| Methocarbamol | Methocarbamol | 25 | 13 |
| Torsemide | Torsemide | 25 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 24 | 17 |
| Tizanidine Hcl | Tizanidine Hcl | 24 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 24 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 23 | 21 |
| Primidone | Primidone | 23 | suppressed |
| Procrit | Epoetin Alfa | 23 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 22 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 22 | 11 |
| Glipizide | Glipizide | 22 | suppressed |
| Levofloxacin | Levofloxacin | 22 | 14 |
| Labetalol Hcl | Labetalol Hcl | 21 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 21 | 12 |
| Sps | Sodium Polystyrene Sulfon/Sorb | 21 | 14 |
| Amoxicillin | Amoxicillin | 20 | 13 |
| Fluconazole | Fluconazole | 20 | 13 |
| Haloperidol | Haloperidol | 20 | suppressed |
| Ketoconazole | Ketoconazole | 20 | 11 |
| Lovastatin | Lovastatin | 20 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 20 | suppressed |
| Brilinta | Ticagrelor | 19 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 19 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 19 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 18 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 18 | suppressed |
| Restasis | Cyclosporine | 18 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 17 | suppressed |
| Carbamazepine | Carbamazepine | 17 | suppressed |
| Cefepime Hcl | Cefepime Hcl | 17 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 17 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 17 | suppressed |
| Novolog | Insulin Aspart | 17 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 17 | suppressed |
| Trulicity | Dulaglutide | 17 | suppressed |
| Admelog Solostar | Insulin Lispro | 16 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 16 | suppressed |
| Atenolol | Atenolol | 16 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 16 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 16 | suppressed |
| Clonidine | Clonidine | 16 | suppressed |
| Glipizide Er | Glipizide | 16 | suppressed |
| Glucagon Emergency Kit | Glucagon | 16 | 11 |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 16 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 16 | suppressed |
| Budesonide | Budesonide | 15 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 15 | suppressed |
| Metolazone | Metolazone | 15 | suppressed |
| Mycophenolate Mofetil | Mycophenolate Mofetil | 15 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 15 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 14 | suppressed |
| Aptiom | Eslicarbazepine Acetate | 14 | suppressed |
| Calcitriol | Calcitriol | 14 | suppressed |
| Hydrocortisone | Hydrocortisone | 14 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 14 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 14 | suppressed |
| Metronidazole | Metronidazole | 14 | suppressed |
| Ondansetron Odt | Ondansetron | 14 | suppressed |
| Tradjenta | Linagliptin | 14 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 13 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 13 | suppressed |
| Daptomycin | Daptomycin | 13 | suppressed |
| Ertapenem | Ertapenem Sodium | 13 | suppressed |
| Kapspargo Sprinkle | Metoprolol Succinate | 13 | suppressed |
| Nyamyc | Nystatin | 13 | suppressed |
| Ranolazine Er | Ranolazine | 13 | suppressed |
| Tacrolimus | Tacrolimus | 13 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 13 | suppressed |
| Vancomycin Hcl | Vancomycin/Water For Inj (Peg) | 13 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 13 | suppressed |
| Austedo Xr | Deutetrabenazine | 12 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 12 | suppressed |
| Bupropion Xl | Bupropion Hcl | 12 | suppressed |
| Cilostazol | Cilostazol | 12 | suppressed |
| Dexamethasone | Dexamethasone | 12 | suppressed |
| Exelon | Rivastigmine | 12 | suppressed |
| Naloxone Hcl | Naloxone Hcl | 12 | suppressed |
| Ampicillin-Sulbactam | Ampicillin Sod/Sulbactam Sod | 11 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 11 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 11 | suppressed |
| Glimepiride | Glimepiride | 11 | suppressed |
| Mupirocin | Mupirocin | 11 | 11 |
| Oxycodone Hcl | Oxycodone Hcl | 11 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $22.92 · 1 records | Neurocrine BioSciences, Inc. | INGREZZA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error